Tag: Pharmaceuticals
-
Section 232 medical device investigation status. Scope determination, expected rates, industries affected, and SMB MedTech preparedness.
-
Section 232 semiconductor investigation status. Scope determination, expected rates, affected industries, and supply-chain implications.
-
Section 232 derivatives expansion brought downstream fabricated steel and aluminum products into scope. HTS subheadings affected, scope determination, and importer impact.
-
How importers file Section 232 product-specific exclusion petitions through Commerce. Requirements, timeline, approval factors.
-
Country-specific Section 232 exemption arrangements – EU, UK, Japan, Australia, Brazil, Argentina, Korea. Quota arrangements vs. flat tariff rates.
-
How Section 232 tariff-rate quotas (TRQs) work for specific countries. Quota allocations, fill tracking, in-quota vs over-quota rates.
-
USMCA / CUSMA rules of origin for pharmaceuticals. RVC, tariff-shift, sector-specific provisions, qualification documentation.
-
Canadian pharma U.S. trade tariff guide. Section 232 pharma exemption for generics, USMCA qualification, Quebec and Toronto pharma exporters.
-
Mexico pharma exports to the U.S. tariff guide. Section 232 pharma exemption for generics, USMCA qualification, FDA admission.
-
Drawback eligibility for Section 232, Section 301, and Section 122 duties. Recovery scope, documentation, calculation specifics.